Sexual HIV-1 transmission and mucosal defense mechanisms

AIDS Reviews

Volumn 2, Issue 3, 2000, Pages 144-154

  Cummins J E , Jr ^a   Dezzutti, C S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Genital tract; HIV 1; Mucosal immune system; Sexually transmitted diseases; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; ESTROGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROGESTERONE;

CELLULAR IMMUNITY; COST EFFECTIVENESS ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DRUG COST; DRUG EFFECT; DRUG USE; EXPERIMENTAL MODEL; EXPOSURE; FACTORIAL ANALYSIS; FEMALE GENITAL SYSTEM; HETEROSEXUALITY; HIGH RISK POPULATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNITY; IMMUNOMODULATION; INCIDENCE; LYMPHOID TISSUE; MUCOSA; NONHUMAN; PREVALENCE; PRIMATE; REVIEW; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS INHIBITION; VIRUS TRANSMISSION;

EID: 0034544540     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: A study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission
2. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study
3. Per-contact risk of human immunodeficiency virus transmission between male sexual partners
4. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier
5. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM
6. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells
7. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275
8. HIV transmission and immune protection at mucosal surfaces
9. Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for transmission of AIDS
10. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells
11. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides
12. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks
13. Localization of simian immunodeficiency virus-infected cells in the genital tract of male and female rhesus macaques
14. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: Implications for sexual transmission
15. Lack of evidence for productive HIV-1 infection of primary cervical and prostate epithelial cells
16. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract
17. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract
18. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques
19. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
20. Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys
21. Simian immunodeficiency rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells
22. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: Implications for the ontogeny of the CCR5+ Th1 phenotype
23. Repertoire of chemokine receptor expression in the female genital tract: Implications for human immunodeficiency virus transmission
24. Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1
25. Constitutive expression of stromal derived factor-1 by mucosa epithelia and its role in HIV transmission and propagation
26. Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection
27. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
28. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo
29. Association between culturable human immunodeficiency virus type 1 (HIV-1) RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
30. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir
31. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood
32. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1
33. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
34. Human immunodeficiency virus type 1 RNA shedding in the female genital tract
35. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions
36. Quantification of HIV in semen: Correlation with antiviral treatment and immune status
37. Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men
38. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission
39. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner
40. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group
41. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors
42. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
43. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis
44. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
45. Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men
46. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study
47. Immune stimulation and HIV-1 viral replication
48. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix
49. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection
50. Factors determining differences in rate of spread of HIV in sub-Saharan Africa: Results from a population based survey in four African cities
51. Factors associated with changes in HIV shedding in semen
52. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group
53. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire
54. Bacterial vaginosis decreases suppression of female genital tract HIV-1 RNA levels
55. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomised controlled trial
56. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group
57. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials
58. Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract
59. Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle
60. Progesterone implants enhance SIV vaginal transmission and early virus load
61. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys
62. Estrogen protects against vaginal transmission of SIV
63. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya
64. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
65. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA
66. Man-to-woman sexual transmission of HIV: Longitudinal study of 343 steady partners of infected men
67. Contraceptive use and HIV infection in Kenyan family planning clinic attenders
68. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania
69. Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya
70. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1
71. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1
72. A common mucosal immunologic system involving the bronchus, breast and bowel
73. Characteristics and functions of mucosa-associated lymphoid tissue
74. Mucosal immune responses: An overview
75. Gut-associated lymphoid tissue: Antigen handling and T-lymphocyte responses
76. The immunobiology of the tonsils and adenoids
77. Langerhans' cells and lymphocyte subsets in the female genital tract
78. Antigen processing structures of the mammalian intestinal tract: An SEM study of lymphoepithelial organs
79. Epithelial cell specialization within human Peyer's patches: An ultrastructural study of intestinal lymphoid follicles
80. Sequential uptake of horseradish peroxidase by lymphoid follicle epitheliumm of Peyer's patches in the normal unobstructed mouse intestine: An ultrastructural study
81. Microvillus growth and M-cell formation in mouse Peyer's patch follicle-associated epithelial tissue
82. Isolation and functional characteristics of adherent phagocytic cells from mouse Peyer's patches
83. Rabbit peyer's patches, appendix, and popliteal lymph node B lymphocytes: A comparative analysis of their membrane immunoglobulin components and plasma cell precursor potential
84. Immediate IgA precursor cells in rabbit intestinal lamina propria
85. Review and discussion of homing of lymphoid cells to mucosal membranes: The selective localization of cells in mucosal tissues
86. Gut and bronchus associated lymphoid tissue: An overview
87. The emigration of lymphocytes from Peyer's patches in sheep
88. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues
89. The route of recirculation of lymphocytes in the rat
90. A cell-surface molecule involved in organ-specific homing of lymphocytes
91. Human T cell clones express functional homing receptors required for normal lymphocyte trafficking
92. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man
93. Mucosal immunity of the genital tract
94. Systemic and secretory humoral immunity in the normal human vaginal tract
95. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions
96. Mucosal immunoglobulins
97. Glandular distribution of immunoglobulins, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle
98. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion
99. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects
100. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection
101. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp 120 V3 loop in HIV-infected individuals
102. Serum IgA-mediated neutralization of HIV type 1
103. Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity
104. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate
105. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients
106. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons
107. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
108. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
109. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group
110. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
111. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia
112. Intramucosal lymphocytes of the gut: Lyt-2 and thy-1 phenotype of the granulated cells and evidence for the presence of both T cells and mast cell precursors
113. Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria
114. Class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the epithelium of the rat intestine
115. Dendritic cells of the gastrointestinal tract
116. Modulation of epithelial cell growth by intraepithelial gamma delta T cells
117. The importance of mucosal immunology to problems in human reproduction
118. HLA-DR-expressing Langerhan's-like cells in vaginal and cervical epithelium
119. Localization of SIV in the genital tract of chronically infected female rhesus macaques
120. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women
121. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques
122. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens
123. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
124. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
125. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4+ T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
126. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
127. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons
128. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects
129. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
130. Dynamics of HIV variants and specific cytotoxic T-cell recognition in nonprogressors and progressors
131. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
132. Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals
133. A mucosal internet: Epithelial cell-immune cell interactions
134. Innate humoral factors
135. Defensins and other antimicrobial peptides
136. Defensins inhibit HIV replication in vitro
137. Structural and functional similarities between synthetic HIV gp41 peptides and defensins
138. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro
139. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I
140. Endogenous mucosal antiviral factors of the oral cavity
141. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription
142. Components of saliva inactivate human immunodeficiency virus
143. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I
144. The role of the oral environment in HIV-1 transmission
145. High incidence of early postnatal transmission of human immunodeficiency virus type 1 in Bangui, Central African Republic
146. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1
147. Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV
148. Secretory leukocyte protease inhibitor (SLPI) concentrations in seminal plasma: SLPI restores sperm motility reduced by elastase
149. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role
150. Topical microbicides
151. 2-generating lactobacilli
152. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: Possible role in heterosexual transmission
153. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
154. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition